• Roche wins Genentech with raised $46.8 billion offer

    Roche Holding AG has struck a deal with Genentech Inc to acquire all outstanding shares in the U.S. biotech group for $46.8 billion, the Swiss drugmaker said on Thursday.
  • Roche agrees to buy Genentech for $46.8 billion

    Roche Holding AG has struck a deal with Genentech Inc to acquire all outstanding shares in the U.S. biotech group for $46.8 billion, the Swiss drugmaker said on Thursday.
  • Roche says hopes hostile Ventana bid turns friendly

    Swiss drugmaker Roche Holding said on Tuesday it still hoped its $3 billion hostile bid for Ventana Medical Systems Inc. could turn friendly but declined to say whether it would sweeten the deal.